The Connecticut Department of Public Health is recommending that COVID-19 vaccine providers pause on administering the Johnson & Johnson vaccine for the time being while the FDA and CDC investigate reports of potentially dangerous blood clots and several cities, towns and providers are doing just that. The state Department of Public Health said the CDC, FDA and Connecticut DPH all.
The Connecticut Department of Public Health announced Tuesday morning it will pause administration of the Johnson & Johnson vaccine pending a federal investigation into a highly rare potential side effect.
The Connecticut Department of Public Health is recommending that COVID-19 vaccine providers pause on administering the Johnson & Johnson vaccine for the time being while the FDA and CDC investigate reports of potentially dangerous blood clots and several cities, towns and providers are doing just that. The state Department of Public Health said the CDC, FDA and Connecticut DPH all.
CT Pauses of J&J COVID Vaccine After Rare Complications
file photo j&J
The state of Connecticut is pausing the administration of the one-dose Johnson & Johnson vaccine for the time being while the FDA and CDC investigate reports of potentially dangerous blood clots.
Connecticut Pauses Use of the Johnson and Johnson Vaccine
Replay Video UP NEXT
In a joint statement issued on Tuesday morning, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating unusual clots in six women that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48.